T1	SectionAnnotate 225 229	HPI:
T2	SectionAnnotate 3728 3749	Past Medical History:
T3	SectionAnnotate 4050 4064	Family History
T4	SectionAnnotate 4473 4487	Social History
T5	SectionAnnotate 4946 4970	Social History Narrative
T6	SectionSkip 5057 5438	Outpatient Encounter Prescriptions as of 03/08/2017   Medication Sig Dispense Refill    simvastatin (ZOCOR) 20 mg tablet       LORazepam (ATIVAN) 1 mg tablet Take 1 tab po/sl 1 hr prior to scans.  July repeat x 1 at time of scan. (Patient not taking: Reported on 03/08/2017) 10 tablet 0     No facility-administered encounter medications on file as of 03/08/2017.        No Known
T7	SectionAnnotate 5454 5471	Review of Systems
T8	SectionSkip 5741 5798	Allergies: Negative.    Psychiatric/Behavioral: Negative.
 Pulse 66  | Temp 36.1 C (97 F) (Oral)  | Resp 18  | Ht 156.4 cm (5' 1.58") Comment: March 03@***** | Wt 54.5 kg (120 lb 1.6 oz)  | LMP 04/06/2008  | SpO2 96%  | BMI 22.27 kg/m    Constitutional - WDWN, NAD  Eyes - sclera anicteric, PERRL, EOMI  HENT - sinuses nontender, nasal mucosa intact, pharynx without erythema, stomatitis, or thrush   Lymph Nodes - no cervical, supraclavicular, or axillary lymphadenopathy  Respiratory - resonant to percussion throughout, CTA bilaterally; no wheezes, rhonchi, or crackles  Cardiovascular - Normal heart rate, normal rhythm, no murmurs, no edema  Breast - right breast with mass (3 x 4 cm) in lower outer quadrant; left breast without palpable masses  GI - Bowel sounds normal, soft; no tenderness, no distention, no HSM  Musculoskeletal - No tenderness over bones or joints.   Neurologic - Alert & oriented x 3, ambulates w/o difficulty, good strength throughout  Psychiatric - Mood stable; no HI, SI, hallucinations, paranoia, or delusions  Skin - warm without rashes or lesions     Studies:  Available labs, pathology, and imaging were reviewed and independently interpreted, as described above in the HPI.
T10	SectionSkip 7005 7160	Lab Results   Component Value Date    WBC Count 5.6 10/22/2016    Hemoglobin 12.6 10/22/2016    Hematocrit 38.4 10/22/2016    Platelet Count 202 10/22/2016
T11	SectionSkip 7165 7482	Lab Results   Component Value Date    Sodium, Serum / Plasma 139 10/22/2016    Potassium, Serum / Plasma 4.2 10/22/2016    Chloride, Serum / Plasma 106 10/22/2016    Carbon Dioxide, Total 25 10/22/2016    Urea Nitrogen, Serum / Plasma 18 10/22/2016    Creatinine 0.76 10/22/2016    Glucose, non-fasting 120 10/22/2016
T12	SectionSkip 7487 7570	Lab Results   Component Value Date    Calcium, total, Serum / Plasma 9.2 10/22/2016
T13	SectionAnnotate 7577 7608	Assessment and Recommendations:
T14	PROBLEM 85 110	early stage breast cancer
T15	TREATMENT 152 169	treatment options
T16	TREATMENT 252 285	a right breast partial mastectomy
T17	PROBLEM 308 316	a lipoma
T18	PROBLEM 341 351	malignancy
T19	TEST 385 391	an FNA
T20	PROBLEM 483 503	benign breast tissue
T21	PROBLEM 524 528	scar
T22	PROBLEM 533 554	surgical site changes
T23	PROBLEM 620 646	a mass in her right breast
T24	TEST 667 690	a subsequent evaluation
T25	PROBLEM 713 726	breast cancer
T26	TEST 729 739	Evaluation
T27	TEST 775 794	screening mammogram
T28	PROBLEM 796 831	heterogeneously dense breast tissue
T29	PROBLEM 848 858	malignancy
T30	PROBLEM 860 895	right breast post-surgical scarring
T31	TEST 908 927	screening mammogram
T32	PROBLEM 929 964	heterogeneously dense breast tissue
T33	PROBLEM 994 1004	malignancy
T34	TEST 1018 1044	right diagnostic mammogram
T35	PROBLEM 1046 1060	irregular mass
T36	PROBLEM 1066 1121	spiculated margins in lower slightly outer right breast
T37	PROBLEM 1140 1175	heterogeneously dense breast tissue
T38	TEST 1177 1200	Right breast ultrasound
T39	PROBLEM 1202 1222	irregular solid mass
T40	PROBLEM 1249 1295	spiculated margins in lower outer right breast
T41	PROBLEM 1343 1356	palpable lump
T42	PROBLEM 1359 1379	irregular solid mass
T43	PROBLEM 1406 1452	spiculated margins in lower outer right breast
T44	PROBLEM 1489 1516	a 2nd smaller palpable lump
T45	TEST 1598 1601	FNA
T46	PROBLEM 1638 1652	adenocarcinoma
T47	TEST 1666 1668	US
T48	TEST 1669 1687	guided core biopsy
T49	PROBLEM 1691 1708	right breast mass
T50	PROBLEM 1745 1786	1.2 cm grade 2 invasive mammary carcinoma
T51	PROBLEM 1792 1825	mixed ductal and lobular features
T52	TEST 1827 1829	ER
T53	TEST 1837 1839	PR
T54	TEST 1847 1851	HER2
T55	TEST 1854 1857	IHC
T56	TEST 1861 1871	FISH ratio
T57	TEST 1879 1884	Ki-67
T58	TEST 1891 1893	US
T59	TEST 1894 1917	guided right breast FNA
T60	TEST 1956 1974	adenocarcinoma  US
T61	TEST 1975 1998	guided right breast FNA
T62	PROBLEM 2035 2049	adenocarcinoma
T63	TEST 2062 2072	Breast MRI
T64	PROBLEM 2074 2097	irregularly shaped mass
T65	PROBLEM 2124 2170	spiculated margins in lower outer right breast
T66	PROBLEM 2189 2207	7:00 position mass
T67	TEST 2211 2213	US
T68	TEST 2218 2226	palpable
T69	TEST 2227 2244	FNA guided biopsy
T70	PROBLEM 2252 2261	carcinoma
T71	PROBLEM 2297 2353	slightly superior and lateral to biopsy proven carcinoma
T72	PROBLEM 2355 2382	an irregular enhancing mass
T73	PROBLEM 2422 2440	8:00 position mass
T74	TEST 2444 2446	US
T75	PROBLEM 2449 2482	enhancing oval circumscribed mass
T76	PROBLEM 2534 2547	position mass
T77	PROBLEM 2553 2562	faint NME
T78	PROBLEM 2620 2629	this mass
T79	PROBLEM 2634 2644	adenopathy
T80	PROBLEM 2648 2670	chest wall involvement
T81	TEST 2709 2715	PET/CT
T82	PROBLEM 2732 2750	metastatic disease
T83	PROBLEM 2752 2806	2 hypermetabolic enhancing nodules within right breast
T84	PROBLEM 2808 2881	sclerotic foci within left ileum, right pubic symphysis, and left ischium
T85	PROBLEM 2902 2914	bone islands
T86	PROBLEM 2916 2950	mild uptake along distal esophagus
T87	PROBLEM 2959 2971	esophagitis)
T88	PROBLEM 3161 3174	breast cancer
T89	PROBLEM 3492 3514	very irregular periods
T90	TREATMENT 3546 3552	Clomid
T91	TREATMENT 3634 3643	menopause
T92	PROBLEM 3656 3667	nightsweats
T93	PROBLEM 3682 3693	hot flashes
T94	PROBLEM 3718 3721	HRT
T95	PROBLEM 3771 3784	Breast cancer
T96	PROBLEM 3790 3816	Fibrocystic breast disease
T97	PROBLEM 3822 3850	Lipoma     (R) breast lipoma
T98	PROBLEM 3855 3863	Melanoma
T99	TREATMENT 3940 3983	Excisional Biopsy of Breast      (R) breast
T100	TREATMENT 3988 4004	KNEE ARTHROSCOPY
T101	PROBLEM 4005 4028	Left     plica syndrome
T102	PROBLEM 4101 4114	Breast cancer
T103	TREATMENT 4142 4163	unilateral mastectomy
T104	PROBLEM 4194 4207	Heart failure
T105	PROBLEM 4230 4243	Breast cancer
T106	PROBLEM 4290 4298	Lymphoma
T107	TREATMENT 4330 4342	chemotherapy
T108	TREATMENT 4367 4379	chemotherapy
T109	PROBLEM 4384 4395	Lung cancer
T110	TREATMENT 5146 5165	simvastatin (ZOCOR)
T111	TREATMENT 5186 5204	LORazepam (ATIVAN)
T112	TEST 5248 5253	scans
T113	TEST 5283 5287	scan
T114	TREATMENT 5385 5396	medications
T115	PROBLEM 5433 5448	Known Allergies
T116	TEST 5824 5835	Vital Signs
T117	TEST 5838 5840	BP
T118	TEST 5853 5858	Pulse
T119	TEST 5865 5869	Temp
T120	TEST 5875 5876	C
T121	TEST 5894 5898	Resp
T122	TEST 5905 5907	Ht
T123	TEST 5954 5956	Wt
T124	TEST 5984 5987	LMP
T125	TEST 6002 6006	SpO2
T126	TEST 6014 6017	BMI
T127	PROBLEM 6055 6058	NAD
T128	PROBLEM 6074 6083	anicteric
T129	PROBLEM 6113 6122	nontender
T130	PROBLEM 6161 6169	erythema
T131	PROBLEM 6171 6181	stomatitis
T132	PROBLEM 6186 6206	thrush   Lymph Nodes
T133	PROBLEM 6212 6266	cervical, supraclavicular, or axillary lymphadenopathy
T134	TEST 6294 6304	percussion
T135	TEST 6317 6320	CTA
T136	PROBLEM 6337 6344	wheezes
T137	PROBLEM 6346 6353	rhonchi
T138	PROBLEM 6358 6366	crackles
T139	PROBLEM 6422 6429	murmurs
T140	PROBLEM 6434 6439	edema
T141	PROBLEM 6468 6472	mass
T142	PROBLEM 6529 6544	palpable masses
T143	PROBLEM 6581 6591	tenderness
T144	PROBLEM 6596 6606	distention
T145	PROBLEM 6611 6614	HSM
T146	PROBLEM 6637 6668	tenderness over bones or joints
T147	PROBLEM 6789 6791	HI
T148	PROBLEM 6793 6795	SI
T149	PROBLEM 6797 6811	hallucinations
T150	PROBLEM 6813 6821	paranoia
T151	PROBLEM 6826 6835	delusions
T152	PROBLEM 6857 6863	rashes
T153	PROBLEM 6867 6874	lesions
T154	TEST 6889 6903	Available labs
T155	TEST 6905 6914	pathology
T156	TEST 6920 6927	imaging
T157	TEST 7043 7046	WBC
T158	TEST 7047 7052	Count
T159	TEST 7071 7081	Hemoglobin
T160	TEST 7101 7111	Hematocrit
T161	TEST 7131 7145	Platelet Count
T162	TEST 7165 7176	Lab Results
T163	TEST 7189 7194	Value
T164	TEST 7203 7209	Sodium
T165	TEST 7211 7216	Serum
T166	TEST 7219 7225	Plasma
T167	TEST 7244 7253	Potassium
T168	TEST 7255 7260	Serum
T169	TEST 7263 7269	Plasma
T170	TEST 7288 7296	Chloride
T171	TEST 7298 7303	Serum
T172	TEST 7306 7312	Plasma
T173	TEST 7331 7345	Carbon Dioxide
T174	TEST 7370 7383	Urea Nitrogen
T175	TEST 7385 7390	Serum
T176	TEST 7393 7399	Plasma
T177	TEST 7417 7427	Creatinine
T178	TEST 7447 7454	Glucose
T179	TEST 7456 7467	non-fasting
T180	TEST 7487 7498	Lab Results
T181	TEST 7511 7516	Value
T182	TEST 7525 7532	Calcium
T183	TEST 7541 7555	Serum / Plasma
T184	TEST 7577 7587	Assessment
T185	PROBLEM 7646 7668	a clinical stage II HR
T186	TREATMENT 7735 7746	neoadjuvant
T187	TREATMENT 7750 7771	adjuvant chemotherapy
T188	TREATMENT 7863 7872	treatment
T189	PROBLEM 7914 7953	node-negative HR positive breast cancer
T190	TREATMENT 8003 8029	the multimodality approach
T191	TREATMENT 8033 8056	breast cancer treatment
T192	PROBLEM 8114 8132	metastatic disease
T193	TREATMENT 8174 8189	curative intent
T194	TREATMENT 8221 8234	her treatment
T195	TREATMENT 8248 8260	chemotherapy
T196	TREATMENT 8262 8269	surgery
T197	TREATMENT 8271 8287	hormonal therapy
T198	TREATMENT 8302 8311	radiation
T199	TREATMENT 8354 8366	chemotherapy
T200	TREATMENT 8370 8393	the neoadjuvant setting
T201	TREATMENT 8425 8434	treatment
T202	TREATMENT 8467 8492	breast conserving surgery
T203	TREATMENT 8507 8532	the chemotherapy regimens
T204	TREATMENT 8602 8616	these regimens
T205	TREATMENT 8712 8717	ISPY2
T206	TREATMENT 8798 8810	the regimens
T207	PROBLEM 8847 8849	HR
T208	PROBLEM 8851 8864	breast cancer
T209	TREATMENT 8870 8882	chemotherapy
T210	TREATMENT 8928 8941	AC/T (or T/AC
T211	TREATMENT 8960 8971	doxorubicin
T212	TREATMENT 8977 8998	cyclophosphamide (AC)
T213	TREATMENT 9038 9055	weekly paclitaxel
T214	TREATMENT 9091 9100	docetaxel
T215	TREATMENT 9106 9127	cyclophosphamide (TC)
T216	TREATMENT 9193 9211	the Anthracyclines
T217	TEST 9267 9283	node-negative HR
T218	PROBLEM 9285 9289	HER2
T219	PROBLEM 9291 9304	breast cancer
T220	TREATMENT 9342 9348	taxane
T221	TREATMENT 9349 9370	anthracyline regimens
T222	TREATMENT 9388 9390	TC
T223	TREATMENT 9440 9442	TC
T224	TREATMENT 9446 9467	a neoadjuvant regimen
T225	TREATMENT 9521 9528	surgery
T226	PROBLEM 9571 9582	positive LN
T227	TREATMENT 9599 9601	TC
T228	TREATMENT 9652 9668	an anthracycline
T229	TREATMENT 9714 9734	chemotherapy upfront
T230	TREATMENT 9750 9755	chemo
T231	TREATMENT 9837 9849	a lumpectomy
T232	TREATMENT 9894 9906	a mastectomy
T233	PROBLEM 10008 10012	AC/T
T234	PROBLEM 10022 10029	fatigue
T235	PROBLEM 10031 10041	neuropathy
T236	PROBLEM 10043 10064	skin and nail changes
T237	PROBLEM 10066 10074	myalgias
T238	PROBLEM 10076 10084	alopecia
T239	PROBLEM 10086 10102	myelosuppression
T240	PROBLEM 10104 10110	nausea
T241	TREATMENT 10149 10151	AC
T242	PROBLEM 10178 10192	cardiotoxicity
T243	PROBLEM 10240 10281	asymptomatic or symptomatic heart failure
T244	PROBLEM 10287 10294	dyspnea
T245	PROBLEM 10299 10309	chest pain
T246	PROBLEM 10356 10373	an increased risk
T247	PROBLEM 10384 10403	secondary leukemias
T248	TREATMENT 10497 10518	neoadjuvant treatment
T249	TREATMENT 10541 10565	neoadjuvant chemotherapy
T250	TREATMENT 10604 10613	treatment
T251	TREATMENT 10638 10659	chemotherapy teaching
T252	TEST 10671 10688	an echocardiogram
T253	TREATMENT 10821 10827	a port
T254	TEST 10924 10938	echocardiogram
T255	TREATMENT 10942 10953	chemo teach
T256	TREATMENT 10957 10971	port placement
T257	TREATMENT 11040 11042	AC
T258	TREATMENT 11282 11300	the treatment plan
T259	TREATMENT 11317 11333	medication risks
T260	TREATMENT 11335 11357	lifestyle modification
T261	TREATMENT 11385 11392	surgery
T262	PROBLEM 11394 11402	symptoms
T263	TREATMENT 11407 11426	therapeutic options
T264	Age 27 29	67
T265	PatientCharacteristics 35 49	postmenopausal
T266	ClinicalCondition 97 110	breast cancer
A1	ContinuityVal T266 new
T267	Stage 85 90	early
T268	Datetime 289 297	07/06/14
T269	ProcedureName 267 285	partial mastectomy
A2	IntentVal T269 treatment-curative
A3	TreatmentTypeVal T269 local
A4	TreatmentCategory T269 Others
A5	IsTumorRemaining T269 no
R1	HappensAtOnDuring Arg1:T269 Arg2:T268	
T270	Site 263 264	a
T271	Laterality 254 259	right
R2	LateralityOfSite Arg1:T271 Arg2:T270	
R3	SiteOf Arg1:T270 Arg2:T269	
T272	Histology 310 316	lipoma
A6	HistoryVal T272 history
A7	EpisodeDescription T272 FirstOccurrence
R4	TestOrProcedureConductedForProblem Test:T269 Prob:T272	
T273	Histology 341 351	malignancy
A8	NegationModalityVal T273 negated
T274	Pathology 388 391	FNA
A9	IntentVal T274 screening
T275	Datetime 459 467	11/09/14
R5	HappensAtOnDuring Arg1:T274 Arg2:T275	
T276	Site 405 411;419 455	breast 9:00 position, 11 cm from the nipple
T277	Laterality 399 404	right
R6	LateralityOfSite Arg1:T277 Arg2:T276	
R7	SiteOf Arg1:T276 Arg2:T274	
T278	Histology 483 503	benign breast tissue
R8	TestOrProcedureReveals Test:T274 Desc:T278	
T279	Radiology 572 581	mammogram
A10	IntentVal T279 screening
T280	Datetime 585 594	June 2015
T281	Datetime 599 608	July 2016
R9	HappensAtOnDuring Arg1:T279 Arg2:T280	
R10	HappensAtOnDuring Arg1:T279 Arg2:T281	
T282	RadPathResult 565 571	normal
A11	RadPathResultVal T282 NoDisease
R11	ResultOfTest Desc:T282 Test:T279	
T283	Datetime 650 662	late January
T284	Symptom 622 626	mass
A12	IsPresentOnFirstCancerDiagnosis T284 yes
A13	IsCausedByDiagnosedCancer T284 yes
A14	ChronicVal T284 non-chronic
A15	ContinuityVal T284 new
T285	Site 640 646	breast
T286	Laterality 634 639	right
R12	LateralityOfSite Arg1:T286 Arg2:T285	
R13	SiteOf Arg1:T285 Arg2:T284	
R14	HappensAtOnDuring Arg1:T284 Arg2:T283	
T287	ClinicalCondition 713 726	breast cancer
A16	ContinuityVal T287 new
T288	Datetime 766 774	07/12/15
T289	Radiology 785 794	mammogram
A17	IntentVal T289 screening
R15	HappensAtOnDuring Arg1:T288 Arg2:T289	
T290	RadPathResult 833 858	no features of malignancy
A18	RadPathResultVal T290 NoDisease
R16	ResultOfTest Desc:T290 Test:T289	
T291	Datetime 899 907	07/16/16
T292	Radiology 918 927	mammogram
A19	IntentVal T292 screening
R17	HappensAtOnDuring Arg1:T291 Arg2:T292	
T293	RadPathResult 966 968;994 1004	no malignancy
A20	RadPathResultVal T293 NoDisease
R18	ResultOfTest Desc:T293 Test:T292	
T294	Datetime 1009 1017	02/15/17
T295	Radiology 1035 1044	mammogram
A21	IntentVal T295 diagnosis
T296	Site 1018 1023	right
R19	SiteOf Arg1:T296 Arg2:T295	
T297	RadPathResult 1046 1084	irregular mass with spiculated margins
A22	RadPathResultVal T297 InitialCancerDiagnosis
T298	Site 1088 1093;1103 1108;1115 1121	lower outer breast
T299	Laterality 1109 1114	right
R20	LateralityOfSite Arg1:T299 Arg2:T298	
R21	SiteOf Arg1:T298 Arg2:T297	
T300	Radiology 1190 1200	ultrasound
A23	IntentVal T300 diagnosis
T301	Site 1183 1189	breast
T302	Laterality 1177 1182	Right
R22	LateralityOfSite Arg1:T302 Arg2:T301	
R23	SiteOf Arg1:T301 Arg2:T300	
R24	HappensAtOnDuring Arg1:T294 Arg2:T295	
T303	RadPathResult 1202 1222;1249 1267	irregular solid mass spiculated margins
A24	RadPathResultVal T303 InitialCancerDiagnosis
T304	Site 1271 1282;1289 1295;1299 1330	lower outer breast 7:00 position, 5 cm from nipple
T305	Laterality 1283 1288	right
R25	LateralityOfSite Arg1:T305 Arg2:T304	
R26	SiteOf Arg1:T304 Arg2:T303	
R27	ResultOfTest Desc:T303 Test:T300	
T306	Size 1224 1242	2.4 x 1.5 x 1.5 cm
A25	HistoryVal T306 new
A26	EpisodeDescription T306 FirstOccurrence
T307	RadPathResult 1359 1379;1406 1424	irregular solid mass spiculated margins
A27	RadPathResultVal T307 InitialCancerDiagnosis
T308	Size 1381 1399	1.0 x 1.0 x 0.7 cm
A28	HistoryVal T308 new
A29	EpisodeDescription T308 FirstOccurrence
T309	Site 1428 1439;1446 1452;1456 1487	lower outer breast 8:00 position, 5 cm from nipple
T310	Laterality 1440 1445	right
R28	LateralityOfSite Arg1:T310 Arg2:T309	
R29	SiteOf Arg1:T309 Arg2:T307	
R30	ResultOfTest Desc:T307 Test:T300	
T311	Pathology 1598 1601	FNA
A30	IntentVal T311 diagnosis
T312	Site 1591 1597;1605 1636	breast 7:00 position, 4 cm from nipple
T313	Laterality 1585 1590	right
R31	LateralityOfSite Arg1:T313 Arg2:T312	
R32	SiteOf Arg1:T312 Arg2:T311	
T314	Histology 1638 1652	adenocarcinoma
A31	HistoryVal T314 new
A32	EpisodeDescription T314 FirstOccurrence
R33	TestOrProcedureReveals Test:T311 Desc:T314	
T315	Datetime 1656 1664	02/22/17
T316	Pathology 1666 1687	US-guided core biopsy
A33	IntentVal T316 diagnosis
T317	Site 1697 1743	breast mass at 7:00 position, 5 cm from nipple
T318	Laterality 1691 1696	right
R34	LateralityOfSite Arg1:T318 Arg2:T317	
R35	SiteOf Arg1:T317 Arg2:T316	
R36	HappensAtOnDuring Arg1:T316 Arg2:T315	
T320	Grade 1758 1759	2
A36	HistoryVal T320 new
A37	EpisodeDescription T320 FirstOccurrence
T321	Size 1745 1751	1.2 cm
A38	HistoryVal T321 new
A39	EpisodeDescription T321 FirstOccurrence
R37	TestOrProcedureReveals Test:T316 Desc:T321	
R38	TestOrProcedureReveals Test:T316 Desc:T320	
T322	BiomarkerName 1827 1829	ER
A40	HistoryVal T322 new
A41	EpisodeDescription T322 FirstOccurrence
T319	Histology 1769 1825	mammary carcinoma with mixed ductal and lobular features
A34	HistoryVal T319 new
A35	EpisodeDescription T319 FirstOccurrence
T323	LocalInvasion 1760 1768	invasive
A42	HistoryVal T323 new
A43	EpisodeDescription T323 FirstOccurrence
R39	TestOrProcedureReveals Test:T316 Desc:T323	
R40	TestOrProcedureReveals Test:T316 Desc:T319	
T324	BiomarkerResult 1829 1835	+ >95%
A44	HistoryVal T324 new
A45	EpisodeDescription T324 FirstOccurrence
A46	BiomarkerResultVal T324 Positive
T325	BiomarkerName 1837 1839	PR
A47	HistoryVal T325 new
A48	EpisodeDescription T325 FirstOccurrence
T326	BiomarkerResult 1839 1845	+ ~70%
A49	HistoryVal T326 new
A50	EpisodeDescription T326 FirstOccurrence
A51	BiomarkerResultVal T326 Positive
T327	BiomarkerName 1847 1851	HER2
A52	HistoryVal T327 new
A53	EpisodeDescription T327 FirstOccurrence
T328	BiomarkerResult 1851 1852	-
A54	HistoryVal T328 new
A55	EpisodeDescription T328 FirstOccurrence
A56	BiomarkerResultVal T328 Negative
R41	BiomarkerRel Arg1:T322 Arg2:T324	
R42	BiomarkerRel Arg1:T325 Arg2:T326	
R43	BiomarkerRel Arg1:T327 Arg2:T328	
T330	RadPathResult 1872 1876	0.65
A58	RadPathResultVal T330 InitialCancerDiagnosis
T331	Pathology 1879 1884	Ki-67
A59	IntentVal T331 diagnosis
T332	RadPathResult 1885 1889	~20%
A60	RadPathResultVal T332 InitialCancerDiagnosis
R45	ResultOfTest Desc:T332 Test:T331	
R46	TestOrProcedureReveals Test:T316 Desc:T322	
R47	TestOrProcedureReveals Test:T316 Desc:T325	
R48	TestOrProcedureReveals Test:T316 Desc:T327	
T333	Pathology 1891 1900;1914 1917	US-guided FNA
A61	IntentVal T333 diagnosis
T336	Histology 1956 1970	adenocarcinoma
A62	HistoryVal T336 new
A63	EpisodeDescription T336 FirstOccurrence
T338	Datetime 2053 2061	02/19/17
T339	Pathology 1972 1981;1995 1998	US-guided FNA
T334	Laterality 1901 1906	right	
T335	Site 1907 1913;1921 1954	breast 8:00 position, 5 cm from   nipple
R49	LateralityOfSite Arg1:T334 Arg2:T335	
T9	SectionSkip 5807 5850;5853 7003	Physical Exam:   Vital Signs - BP 105/54  | Pulse 66  | Temp 36.1 C (97 F) (Oral)  | Resp 18  | Ht 156.4 cm (5' 1.58") Comment: March 03@***** | Wt 54.5 kg (120 lb 1.6 oz)  | LMP 04/06/2008  | SpO2 96%  | BMI 22.27 kg/m    Constitutional - WDWN, NAD  Eyes - sclera anicteric, PERRL, EOMI  HENT - sinuses nontender, nasal mucosa intact, pharynx without erythema, stomatitis, or thrush   Lymph Nodes - no cervical, supraclavicular, or axillary lymphadenopathy  Respiratory - resonant to percussion throughout, CTA bilaterally; no wheezes, rhonchi, or crackles  Cardiovascular - Normal heart rate, normal rhythm, no murmurs, no edema  Breast - right breast with mass (3 x 4 cm) in lower outer quadrant; left breast without palpable masses  GI - Bowel sounds normal, soft; no tenderness, no distention, no HSM  Musculoskeletal - No tenderness over bones or joints.   Neurologic - Alert & oriented x 3, ambulates w/o difficulty, good strength throughout  Psychiatric - Mood stable; no HI, SI, hallucinations, paranoia, or delusions  Skin - warm without rashes or lesions     Studies:  Available labs, pathology, and imaging were reviewed and independently interpreted, as described above in the HPI.
A64	SectionSkipType T9 physical_exam
R50	TestOrProcedureReveals Test:T333 Desc:T336	
T337	Site 1988 1994;2002 2033	breast 7:00 position, 7 cm from nipple
T340	Laterality 1982 1987	right
R51	LateralityOfSite Arg1:T340 Arg2:T337	
R52	SiteOf Arg1:T337 Arg2:T339	
T341	Histology 2035 2049	adenocarcinoma
A65	HistoryVal T341 new
A66	EpisodeDescription T341 FirstOccurrence
R53	TestOrProcedureReveals Test:T339 Desc:T341	
T342	Radiology 2069 2072	MRI
A67	IntentVal T342 diagnosis
T343	Site 2062 2068	Breast
R54	SiteOf Arg1:T343 Arg2:T342	
R55	HappensAtOnDuring Arg1:T342 Arg2:T338	
T344	RadPathResult 2074 2142	irregularly shaped mass (2.2 x 2.3 x 2.0 cm) with spiculated margins
A68	RadPathResultVal T344 InitialCancerDiagnosis
T345	Site 2146 2157;2164 2170	lower outer breast
T346	Laterality 2158 2163	right
R56	LateralityOfSite Arg1:T346 Arg2:T345	
R57	SiteOf Arg1:T345 Arg2:T344	
R58	ResultOfTest Desc:T344 Test:T342	
T347	RadPathResult 2358 2403	irregular enhancing mass (1.5 x 1.2 x 1.8 cm)
R59	ResultOfTest Desc:T347 Test:T342	
T348	Site 2271 2282;2289 2295	lower outer breast
T349	Laterality 2283 2288	right
R60	LateralityOfSite Arg1:T349 Arg2:T348	
R61	SiteOf Arg1:T348 Arg2:T347	
T350	RadPathResult 2449 2491	enhancing oval circumscribed mass (0.5 cm)
A69	RadPathResultVal T350 InitialCancerDiagnosis
R62	ResultOfTest Desc:T350 Test:T342	
A70	RadPathResultVal T347 InitialCancerDiagnosis
T351	Site 2500 2547	1.5 cm directly posterior to 7:00 position mass
R63	SiteOf Arg1:T351 Arg2:T350	
T352	RadPathResult 2684 2696	unremarkable
A71	RadPathResultVal T352 NoDisease
T353	Site 2677 2683	breast
T354	Laterality 2672 2676	left
R64	LateralityOfSite Arg1:T354 Arg2:T353	
R65	SiteOf Arg1:T353 Arg2:T352	
R66	ResultOfTest Desc:T352 Test:T342	
T355	Datetime 2700 2708	02/20/17
T356	Radiology 2709 2715	PET/CT
A72	NegationModalityVal T356 affirmed
A73	IntentVal T356 staging
T357	Metastasis 2732 2742	metastatic
A74	NegationModalityVal T357 negated
R67	TestOrProcedureReveals Test:T356 Desc:T357	
R68	HappensAtOnDuring Arg1:T355 Arg2:T356	
T358	RadPathResult 2752 2786	2 hypermetabolic enhancing nodules
A75	RadPathResultVal T358 InitialCancerDiagnosis
R69	ResultOfTest Desc:T358 Test:T356	
T359	Site 2800 2806	breast
T360	Laterality 2794 2799	right
R70	LateralityOfSite Arg1:T360 Arg2:T359	
R71	SiteOf Arg1:T359 Arg2:T358	
T361	ClinicalCondition 3161 3174	breast cancer
A76	ExperiencerVal T361 family
T362	PhysicalActivity 3252 3257	swims
A77	IsStoppedOrContinuing T362 continuing
T363	Frequency 3265 3296	many times a week in the summer
R72	Temporal Arg1:T362 Arg2:T363	
T364	PhysicalActivity 3298 3303	walks
A78	IsStoppedOrContinuing T364 continuing
T365	Frequency 3315 3320	daily
R73	Temporal Arg1:T364 Arg2:T365	
T366	PhysicalActivity 3332 3344	rides horses
A79	IsStoppedOrContinuing T366 continuing
T367	PatientCharacteristics 3413 3421	menarche
T368	Age 3425 3430	12-13
R74	BeginsOnOrAt Arg1:T367 Arg2:T368	
T369	Symptom 3497 3514	irregular periods
A80	IsCausedByDiagnosedCancer T369 no
T370	MedicationName 3465 3468	OCP
R75	TreatmentAdministeredForProblem Treatment:T370 Prob:T369	
T371	Age 3472 3474	16
T372	Age 3518 3520	16
R76	BeginsOnOrAt Arg1:T370 Arg2:T371	
R77	HappensAtOnDuring Arg1:T369 Arg2:T372	
T373	PatientCharacteristics 3530 3534	G3P2
T374	MedicationName 3546 3552	Clomid
T375	Age 3556 3559	30s
R78	HappensAtOnDuring Arg1:T375 Arg2:T374	
T376	ClinicalCondition 3634 3643	menopause
A81	ChronicVal T376 chronic
T377	Age 3647 3649	57
R79	BeginsOnOrAt Arg1:T376 Arg2:T377	
T378	Symptom 3656 3667	nightsweats
A82	IsCausedByDiagnosedCancer T378 no
T379	Symptom 3682 3693	hot flashes
A83	IsCausedByDiagnosedCancer T379 no
R80	ConditionOrTreatmentCausesProblem Treatment:T376 Prob:T378	
R81	ConditionOrTreatmentCausesProblem Treatment:T376 Prob:T379	
T380	TreatmentType 3718 3721	HRT
A84	NegationModalityVal T380 negated
T381	ClinicalCondition 3855 3871	Melanoma in situ
T382	Datetime 3872 3876	2016
R82	HappensAtOnDuring Arg1:T381 Arg2:T382	
T383	ClinicalCondition 3844 3850	lipoma
T384	Site 3837 3843	breast
R83	SiteOf Arg1:T384 Arg2:T383	
T385	ClinicalCondition 3790 3816	Fibrocystic breast disease
T386	ClinicalCondition 3771 3784	Breast cancer
T387	Pathology 3940 3957	Excisional Biopsy
A85	IntentVal T387 diagnosis
T388	Site 3961 3967	Breast
T389	Laterality 3974 3975	R
R84	LateralityOfSite Arg1:T389 Arg2:T388	
R85	SiteOf Arg1:T388 Arg2:T387	
T390	ProcedureName 3988 4004	KNEE ARTHROSCOPY
T391	ClinicalCondition 4005 4028	Left     plica syndrome
T392	Datetime 4030 4042	12 years ago
R86	HappensAtOnDuring Arg1:T391 Arg2:T392	
T393	ClinicalCondition 4101 4114	Breast cancer
A86	ExperiencerVal T393 family
T394	Age 4127 4136	early 50s
R87	HappensAtOnDuring Arg1:T393 Arg2:T394	
T395	ProcedureName 4142 4164	unilateral mastectomy,
A87	ExperiencerVal T395 family
A88	IntentVal T395 treatment-curative
A89	TreatmentTypeVal T395 local
A90	TreatmentCategory T395 Others
A91	IsTumorRemaining T395 unclear
T396	ClinicalCondition 4194 4207	Heart failure
A92	ChronicVal T396 chronic
A93	ExperiencerVal T396 family
T397	Age 4223 4225	85
R88	BeginsOnOrAt Arg1:T396 Arg2:T397	
T398	ClinicalCondition 4230 4243	Breast cancer
A94	ExperiencerVal T398 family
T399	ClinicalCondition 4290 4298	Lymphoma
A95	ExperiencerVal T399 family
T400	Age 4316 4319	70s
R89	HappensAtOnDuring Arg1:T399 Arg2:T400	
T401	TreatmentType 4330 4342	chemotherapy
A96	ExperiencerVal T401 family
A97	TreatmentIntentVal T401 curative
T402	Age 4346 4348	86
R90	HappensAtOnDuring Arg1:T401 Arg2:T402	
R91	TreatmentAdministeredForProblem Treatment:T401 Prob:T399	
T403	ClinicalCondition 4384 4395	Lung cancer
A98	ExperiencerVal T403 family
T404	Age 4412 4414	56
R92	HappensAtOnDuring Arg1:T403 Arg2:T404	
T405	Employment 4416 4443	owned dry cleaning business
A99	ExperiencerVal T405 family
T406	ConsumptionQuantity 4445 4457	20 year pack
T407	Tobacco 4458 4465	history
A100	ExperiencerVal T407 family
R93	ConsumptionQuantityRel Arg1:T407 Arg2:T406	
T408	MaritalStatus 4527 4534	Married
T409	Tobacco 4711 4717	Smoker
A101	NegationModalityVal T409 negated
T410	Tobacco 4732 4739	tobacco
A102	NegationModalityVal T410 negated
T411	Alcohol 4756 4763	Alcohol
A103	IsStoppedOrContinuing T411 continuing
T412	ConsumptionQuantity 4768 4779	1.2 oz/week
T413	ConsumptionQuantity 4784 4810	2 Glasses of wine per week
R94	ConsumptionQuantityRel Arg1:T412 Arg2:T411	
R95	ConsumptionQuantityRel Arg1:T413 Arg2:T411	
T414	Drugs 4855 4859	Drug
A104	NegationModalityVal T414 negated
T415	Employment 4974 4990	Newspaper editor
T416	LivingCondition 5019 5050	Lives with her husband in *****
A105	SectionSkipType T6 medications
A106	SectionSkipType T10 laboratory
A107	SectionSkipType T11 laboratory
A108	SectionSkipType T12 laboratory
T417	Age 7610 7612	67
T418	ClinicalCondition 7618 7632	postmenopausal
A109	ChronicVal T418 chronic
T419	Stage 7663 7665	II
A110	HistoryVal T419 new
A111	EpisodeDescription T419 FirstOccurrence
T420	BiomarkerName 7666 7668	HR
A112	HistoryVal T420 new
A113	EpisodeDescription T420 FirstOccurrence
T421	BiomarkerName 7670 7674	HER2
A114	HistoryVal T421 new
A115	EpisodeDescription T421 FirstOccurrence
T422	BiomarkerResult 7668 7669	+
A116	HistoryVal T422 new
A117	EpisodeDescription T422 FirstOccurrence
A118	BiomarkerResultVal T422 Positive
T423	BiomarkerResult 7674 7675	-
A119	HistoryVal T423 new
A120	EpisodeDescription T423 FirstOccurrence
A121	BiomarkerResultVal T423 Negative
R96	BiomarkerRel Arg1:T422 Arg2:T420	
R97	BiomarkerRel Arg1:T423 Arg2:T421	
T424	Histology 7676 7679	IDC
A122	HistoryVal T424 new
A123	EpisodeDescription T424 FirstOccurrence
T425	Site 7693 7699	breast
T426	Laterality 7687 7692	right
R98	LateralityOfSite Arg1:T426 Arg2:T425	
R99	SiteOf Arg1:T425 Arg2:T424	
T427	TreatmentType 7759 7771	chemotherapy
A124	NegationModalityVal T427 hypothetical_in_future
A125	TreatmentIntentVal T427 curative
T428	GenomicTest 7701 7703	MP
A126	IntentVal T428 diagnosis
A127	GenomicTestType T428 GeneExpression
T429	GenomicTestResult 7704 7713	high risk
A128	GenomicTestType T429 GeneExpression
R100	ResultOfTest Desc:T429 Test:T428	
T430	GenomicTest 7878 7880	MP
A129	IntentVal T430 treatment-curative
A130	GenomicTestType T430 GeneExpression
T431	GenomicTestResult 7881 7890	high risk
A131	GenomicTestType T431 GeneExpression
R101	ResultOfTest Desc:T431 Test:T430	
T432	BiomarkerName 7928 7930	HR
A132	HistoryVal T432 new
A133	EpisodeDescription T432 FirstOccurrence
T433	BiomarkerResult 7931 7939	positive
A134	HistoryVal T433 new
A135	EpisodeDescription T433 FirstOccurrence
A136	BiomarkerResultVal T433 Positive
T434	ClinicalCondition 7940 7953	breast cancer
T435	LymphNodeInvolvement 7919 7927	negative
A137	NegationModalityVal T435 negated
R102	BiomarkerRel Arg1:T432 Arg2:T433	
R103	TumorDesc TumorDetails:T434 Desc:T435	
R104	TumorDesc TumorDetails:T434 Desc:T432	
T436	Metastasis 8114 8124	metastatic
A138	NegationModalityVal T436 negated
T437	TreatmentType 8248 8260	chemotherapy
A139	NegationModalityVal T437 hypothetical_in_future
A140	TreatmentTypeVal T437 unclear
A141	TreatmentIntentVal T437 curative
T438	TreatmentType 8262 8269	surgery
A142	NegationModalityVal T438 hypothetical_in_future
A143	TreatmentIntentVal T438 curative
T439	TreatmentType 8271 8287	hormonal therapy
A144	NegationModalityVal T439 hypothetical_in_future
A145	TreatmentIntentVal T439 curative
T440	TreatmentType 8302 8311	radiation
A146	NegationModalityVal T440 hypothetical_in_future
A147	TreatmentIntentVal T440 curative
T441	TreatmentType 8354 8366	chemotherapy
A148	NegationModalityVal T441 hypothetical_in_future
A149	TreatmentTypeVal T441 neoadjuvant
A150	TreatmentIntentVal T441 curative
T442	ProcedureName 8467 8492	breast conserving surgery
A151	NegationModalityVal T442 hypothetical_in_future
A152	IntentVal T442 treatment-palliative
A153	TreatmentTypeVal T442 local
A154	TreatmentCategory T442 Others
T443	ClinicalTrial 8658 8664	I-SPY2
A155	NegationModalityVal T443 hypothetical_in_future
T444	ClinicalTrial 8712 8717	ISPY2
A156	NegationModalityVal T444 negated
T445	ClinicalCondition 8851 8864	breast cancer
T446	BiomarkerName 8847 8849	HR
A157	HistoryVal T446 new
A158	EpisodeDescription T446 FirstOccurrence
T447	BiomarkerResult 8849 8850	+
A159	HistoryVal T447 new
A160	EpisodeDescription T447 FirstOccurrence
A161	BiomarkerResultVal T447 Positive
R105	BiomarkerRel Arg1:T447 Arg2:T446	
R106	TumorDesc TumorDetails:T445 Desc:T446	
T448	MedicationRegimen 8928 8932	AC/T
A162	NegationModalityVal T448 hypothetical_in_future
A163	TreatmentTypeVal T448 neoadjuvant
A164	TreatmentIntentVal T448 curative
T449	MedicationRegimen 8937 8941	T/AC
A165	NegationModalityVal T449 hypothetical_in_future
A166	TreatmentTypeVal T449 neoadjuvant
A167	TreatmentIntentVal T449 curative
T450	MedicationName 8960 8971	doxorubicin
A168	NegationModalityVal T450 hypothetical_in_future
A169	TreatmentTypeVal T450 neoadjuvant
A170	TreatmentIntentVal T450 curative
A171	TreatmentCategory T450 AntiNeoPlastics
T451	MedicationName 8977 8993	cyclophosphamide
A172	NegationModalityVal T451 hypothetical_in_future
A173	TreatmentTypeVal T451 neoadjuvant
A174	TreatmentIntentVal T451 curative
A175	TreatmentCategory T451 AntiNeoPlastics
T452	Cycles 8948 8949	4
R107	TreatmentDesc Therapy:T450 Desc:T452	
R108	TreatmentDesc Therapy:T451 Desc:T452	
T453	Frequency 8999 9012	every 2 weeks
R109	Temporal Arg1:T450 Arg2:T453	
R110	Temporal Arg1:T451 Arg2:T453	
T454	Cycles 9025 9027	12
T455	MedicationName 9045 9055	paclitaxel
A176	NegationModalityVal T455 hypothetical_in_future
A177	TreatmentTypeVal T455 neoadjuvant
A178	TreatmentIntentVal T455 curative
A179	TreatmentCategory T455 AntiNeoPlastics
T456	Frequency 9038 9044	weekly
R115	TreatmentDesc Therapy:T455 Desc:T454	
R116	Temporal Arg1:T456 Arg2:T455	
R111	RegimenFor Arg1:T448 Arg2:T451	
R112	RegimenFor Arg1:T448 Arg2:T455	
T457	MedicationName 9091 9100	docetaxel
A180	NegationModalityVal T457 hypothetical_in_future
A181	TreatmentTypeVal T457 neoadjuvant
A182	TreatmentIntentVal T457 curative
A183	TreatmentCategory T457 AntiNeoPlastics
T458	MedicationName 9106 9122	cyclophosphamide
A184	NegationModalityVal T458 hypothetical_in_future
A185	TreatmentTypeVal T458 neoadjuvant
A186	TreatmentIntentVal T458 curative
A187	TreatmentCategory T458 AntiNeoPlastics
T459	Frequency 9135 9148	every 3 weeks
T460	Cycles 9153 9159	4 to 6
R113	Temporal Arg1:T457 Arg2:T459	
R114	Temporal Arg1:T458 Arg2:T459	
R117	TreatmentDesc Therapy:T457 Desc:T460	
R118	TreatmentDesc Therapy:T458 Desc:T460	
R119	RegimenFor Arg1:T457 Arg2:T449	
R120	RegimenFor Arg1:T458 Arg2:T449	
T461	MedicationName 9197 9211	Anthracyclines
A188	NegationModalityVal T461 hypothetical_in_future
A189	TreatmentTypeVal T461 neoadjuvant
A190	TreatmentIntentVal T461 curative
A191	TreatmentCategory T461 AntiNeoPlastics
T462	ClinicalTrial 9215 9228	Breast Cancer
T463	UnspecifiedEntity 8751 8779	does not want to participate
T464	MedicationRegimen 9388 9390	TC
A192	NegationModalityVal T464 hypothetical_in_future
A193	TreatmentTypeVal T464 neoadjuvant
A194	TreatmentIntentVal T464 curative
T465	Cycles 9376 9377	6
T466	MedicationName 9342 9348	taxane
A195	NegationModalityVal T466 hypothetical_in_future
A196	TreatmentTypeVal T466 neoadjuvant
A197	TreatmentIntentVal T466 curative
A198	TreatmentCategory T466 AntiNeoPlastics
T467	MedicationName 9349 9361	anthracyline
A199	NegationModalityVal T467 hypothetical_in_future
A200	TreatmentTypeVal T467 neoadjuvant
A201	TreatmentIntentVal T467 curative
A202	TreatmentCategory T467 AntiNeoPlastics
R121	TreatmentDesc Therapy:T466 Desc:T465	
R122	TreatmentDesc Therapy:T467 Desc:T465	
R123	RegimenFor Arg1:T466 Arg2:T464	
R124	RegimenFor Arg1:T467 Arg2:T464	
T468	ClinicalCondition 9291 9304	breast cancer
T469	LymphNodeInvolvement 9272 9280	negative
A203	NegationModalityVal T469 negated
T470	BiomarkerName 9281 9283	HR
T471	BiomarkerName 9285 9289	HER2
T472	BiomarkerResult 9283 9284	+
A204	BiomarkerResultVal T472 Positive
T473	BiomarkerResult 9289 9290	-
A205	BiomarkerResultVal T473 Negative
R125	BiomarkerRel Arg1:T471 Arg2:T473	
R126	BiomarkerRel Arg1:T470 Arg2:T472	
R127	InclusionCriteriaFor Arg1:T469 Arg2:T462	
R128	InclusionCriteriaFor Arg1:T470 Arg2:T462	
R129	InclusionCriteriaFor Arg1:T471 Arg2:T462	
R130	TumorDesc TumorDetails:T468 Desc:T469	
R131	TumorDesc TumorDetails:T468 Desc:T471	
R132	TumorDesc TumorDetails:T468 Desc:T470	
T474	MedicationRegimen 9440 9442	TC
A206	NegationModalityVal T474 hypothetical_in_future
A207	TreatmentTypeVal T474 neoadjuvant
A208	TreatmentIntentVal T474 curative
T475	LymphNodeInvolvement 9580 9582	LN
A209	NegationModalityVal T475 hypothetical_in_future
T476	MedicationRegimen 9599 9601	TC
A210	NegationModalityVal T476 hypothetical_in_future
A211	TreatmentTypeVal T476 neoadjuvant
A212	TreatmentIntentVal T476 curative
T477	MedicationName 9655 9668	anthracycline
A213	NegationModalityVal T477 hypothetical_in_future
A214	TreatmentIntentVal T477 curative
A215	TreatmentCategory T477 AntiNeoPlastics
T478	MedicationRegimen 9812 9816	AC/T
A216	NegationModalityVal T478 planned_in_future
A217	TreatmentContinuityVal T478 planned
A218	TreatmentTypeVal T478 neoadjuvant
A219	TreatmentIntentVal T478 curative
T479	ProcedureName 9839 9849	lumpectomy
A220	NegationModalityVal T479 planned_in_future
A221	IntentVal T479 treatment-curative
A222	TreatmentTypeVal T479 local
A223	TreatmentCategory T479 Others
T480	ProcedureName 9896 9906	mastectomy
A224	NegationModalityVal T480 planned_in_future
A225	IntentVal T480 treatment-curative
A226	TreatmentTypeVal T480 local
A227	TreatmentCategory T480 Others
T481	MedicationRegimen 10008 10012	AC/T
A228	NegationModalityVal T481 planned_in_future
A229	TreatmentContinuityVal T481 planned
A230	TreatmentTypeVal T481 neoadjuvant
A231	TreatmentIntentVal T481 curative
T482	Symptom 10022 10029	fatigue
A232	NegationModalityVal T482 hypothetical_in_future
A233	IsPresentOnFirstCancerDiagnosis T482 no
A234	IsCausedByDiagnosedCancer T482 no
T483	ClinicalCondition 10031 10041	neuropathy
A235	NegationModalityVal T483 hypothetical_in_future
T484	Symptom 10043 10064	skin and nail changes
A236	NegationModalityVal T484 hypothetical_in_future
A237	IsPresentOnFirstCancerDiagnosis T484 no
A238	IsCausedByDiagnosedCancer T484 no
T485	Symptom 10066 10074	myalgias
A239	NegationModalityVal T485 hypothetical_in_future
A240	IsPresentOnFirstCancerDiagnosis T485 no
A241	IsCausedByDiagnosedCancer T485 no
T486	ClinicalCondition 10076 10084	alopecia
A242	NegationModalityVal T486 hypothetical_in_future
T487	ClinicalCondition 10086 10102	myelosuppression
A243	NegationModalityVal T487 hypothetical_in_future
T488	Symptom 10104 10110	nausea
A244	NegationModalityVal T488 hypothetical_in_future
A245	IsPresentOnFirstCancerDiagnosis T488 no
A246	IsCausedByDiagnosedCancer T488 no
R133	ConditionOrTreatmentCausesProblem Treatment:T481 Prob:T482	
R134	ConditionOrTreatmentCausesProblem Treatment:T481 Prob:T483	
R135	ConditionOrTreatmentCausesProblem Treatment:T481 Prob:T484	
R136	ConditionOrTreatmentCausesProblem Treatment:T481 Prob:T485	
R137	ConditionOrTreatmentCausesProblem Treatment:T481 Prob:T486	
R138	TreatmentAdministeredForProblem Treatment:T449 Prob:T445	
R139	TreatmentAdministeredForProblem Treatment:T448 Prob:T445	
R140	TreatmentAdministeredForProblem Treatment:T437 Prob:T434	
R141	TreatmentAdministeredForProblem Treatment:T438 Prob:T434	
R142	TreatmentAdministeredForProblem Treatment:T439 Prob:T434	
R143	TreatmentAdministeredForProblem Treatment:T440 Prob:T434	
R144	ConditionOrTreatmentCausesProblem Treatment:T481 Prob:T487	
R145	ConditionOrTreatmentCausesProblem Treatment:T481 Prob:T488	
T489	MedicationName 10149 10151	AC
A247	NegationModalityVal T489 planned_in_future
A248	TreatmentContinuityVal T489 planned
A249	TreatmentTypeVal T489 neoadjuvant
A250	TreatmentIntentVal T489 curative
A251	TreatmentCategory T489 AntiNeoPlastics
T490	Symptom 10178 10192	cardiotoxicity
A252	NegationModalityVal T490 hypothetical_in_future
A253	IsPresentOnFirstCancerDiagnosis T490 no
A254	IsCausedByDiagnosedCancer T490 no
T491	ClinicalCondition 10268 10281	heart failure
A255	NegationModalityVal T491 hypothetical_in_future
A256	ChronicVal T491 chronic
T492	Symptom 10287 10294	dyspnea
A257	NegationModalityVal T492 hypothetical_in_future
A258	IsPresentOnFirstCancerDiagnosis T492 no
A259	IsCausedByDiagnosedCancer T492 no
T493	Symptom 10299 10309	chest pain
A260	NegationModalityVal T493 hypothetical_in_future
A261	IsPresentOnFirstCancerDiagnosis T493 no
A262	IsCausedByDiagnosedCancer T493 no
R146	ConditionOrTreatmentCausesProblem Treatment:T489 Prob:T490	
R147	ConditionOrTreatmentCausesProblem Treatment:T489 Prob:T491	
R148	ConditionOrTreatmentCausesProblem Treatment:T489 Prob:T492	
R149	ConditionOrTreatmentCausesProblem Treatment:T489 Prob:T493	
T494	MedicationName 10334 10336	AC
A263	NegationModalityVal T494 planned_in_future
A264	TreatmentContinuityVal T494 planned
A265	TreatmentTypeVal T494 neoadjuvant
A266	TreatmentIntentVal T494 curative
A267	TreatmentCategory T494 AntiNeoPlastics
T495	ClinicalCondition 10384 10403	secondary leukemias
A268	NegationModalityVal T495 hypothetical_in_future
R150	ConditionOrTreatmentCausesProblem Treatment:T494 Prob:T495	
T496	MedicationRegimen 10580 10584	AC/T
A269	NegationModalityVal T496 planned_in_future
A270	TreatmentContinuityVal T496 planned
A271	TreatmentTypeVal T496 neoadjuvant
A272	TreatmentIntentVal T496 curative
T497	Radiology 10674 10688	echocardiogram
A274	IntentVal T497 screening
T498	Radiology 10924 10938	echocardiogram
A275	NegationModalityVal T498 planned_in_future
A276	IntentVal T498 screening
T499	ProcedureName 10957 10971	port placement
A273	NegationModalityVal T499 planned_in_future
A277	IntentVal T499 others
A278	TreatmentTypeVal T499 others
A279	TreatmentCategory T499 Others
T500	ProcedureName 10991 11003	cold cap CRC
A280	NegationModalityVal T500 hypothetical_in_future
T501	ProcedureName 10719 10728	cold caps
A281	NegationModalityVal T501 hypothetical_in_future
T502	MedicationName 11040 11042	AC
A282	NegationModalityVal T502 planned_in_future
A283	TreatmentContinuityVal T502 planned
A284	TreatmentTypeVal T502 neoadjuvant
A285	TreatmentIntentVal T502 curative
A286	TreatmentCategory T502 AntiNeoPlastics
T503	Datetime 11073 11094	March 19 or March 20)
R151	BeginsOnOrAt Arg1:T502 Arg2:T503	
T329	Pathology 1861 1865	FISH
R44	ResultOfTest Desc:T330 Test:T329	
T504	Pathology 2227 2244	FNA guided biopsy
T505	Radiology 2211 2213	US
T506	RadPathResult 2203 2207	mass
A57	RadPathResultVal T506 InitialCancerDiagnosis
T507	Site 2189 2202	7:00 position
R152	SiteOf Arg1:T507 Arg2:T506	
R153	ResultOfTest Desc:T506 Test:T505	
T508	Histology 2252 2261	carcinoma
A287	HistoryVal T508 new
A288	EpisodeDescription T508 FirstOccurrence
R154	TestOrProcedureReveals Test:T504 Desc:T508	
R155	TumorDesc TumorDetails:T267 Desc:T266	
R156	HappensAtOnDuring Arg1:T268 Arg2:T273	
R157	HappensAfter Arg1:T283 Arg2:T287	
A290	NegationModalityVal T290 affirmed
R158	HappensAtOnDuring Arg1:T294 Arg2:T300	
R159	SizeOf Arg1:T306 Arg2:T303	
R160	TestOrProcedureReveals Test:T300 Desc:T306	
R161	SizeOf Arg1:T308 Arg2:T307	
R162	TestOrProcedureReveals Test:T300 Desc:T308	
R163	HappensAtOnDuring Arg1:T294 Arg2:T311	
R164	SizeOf Arg1:T321 Arg2:T319	
R165	HappensAtOnDuring Arg1:T315 Arg2:T333	
R166	HappensAtOnDuring Arg1:T315 Arg2:T339	
R167	SiteOf Arg1:T335 Arg2:T333	
T509	PatientCharacteristics 3566 3581	first pregnancy
T510	Age 3589 3591	30
R168	HappensAtOnDuring Arg1:T509 Arg2:T510	
T511	ConsumptionQuantity 4830 4850	2-3 gl wine per week
R169	ConsumptionQuantityRel Arg1:T411 Arg2:T511	
A289	ExperiencerVal T462 others
T512	Pathology 1854 1857	IHC
T513	RadPathResult 1858 1859	0
R170	ResultOfTest Desc:T513 Test:T512	
T514	RadPathResult 2959 2970	esophagitis
A291	NegationModalityVal T514 uncertain_in_present
R171	ResultOfTest Desc:T514 Test:T356	
R172	InclusionCriteriaFor Arg1:T429 Arg2:T427	
R173	InclusionCriteriaFor Arg1:T424 Arg2:T427	
R174	InclusionCriteriaFor Arg1:T419 Arg2:T427	
R175	InclusionCriteriaFor Arg1:T420 Arg2:T427	
R176	InclusionCriteriaFor Arg1:T421 Arg2:T427	
T515	TreatmentType 8870 8882	chemotherapy
A292	NegationModalityVal T515 hypothetical_in_future
A293	TreatmentTypeVal T515 neoadjuvant
A294	TreatmentIntentVal T515 curative
T516	TreatmentType 9714 9726	chemotherapy
A295	NegationModalityVal T516 hypothetical_in_future
A296	TreatmentTypeVal T516 neoadjuvant
A297	TreatmentIntentVal T516 curative
T517	TreatmentType 9750 9755	chemo
A298	NegationModalityVal T517 hypothetical_in_future
A299	TreatmentTypeVal T517 neoadjuvant
A300	TreatmentIntentVal T517 curative
R177	InclusionCriteriaFor Arg1:T446 Arg2:T449	
R178	InclusionCriteriaFor Arg1:T446 Arg2:T448	
R179	InclusionCriteriaFor Arg1:T446 Arg2:T450	
R180	InclusionCriteriaFor Arg1:T446 Arg2:T451	
R181	InclusionCriteriaFor Arg1:T446 Arg2:T455	
R182	InclusionCriteriaFor Arg1:T446 Arg2:T457	
R183	InclusionCriteriaFor Arg1:T446 Arg2:T458	
R184	ExclusionCriteriaFor Arg1:T475 Arg2:T474	
A301	ExperiencerVal T468 others
A302	ExperiencerVal T472 others
A303	ExperiencerVal T473 others
A304	ExperiencerVal T470 others
A305	ExperiencerVal T471 others
A306	ExperiencerVal T469 others
T518	hpi_start 0 2	ID
T519	hpi_end 3718 3722	HRT.
T520	ap_start 7577 7587	Assessment
T521	ap_end 11137 11143	weeks.
